204
Views
1
CrossRef citations to date
0
Altmetric
Original Research

Factors Affecting the Risk of Brain Metastasis in Limited-Stage Small Cell Lung Cancer After Prophylactic Cranial Irradiation

, , &
Pages 1807-1814 | Published online: 23 May 2022

References

  • Hirsch FR, Matthews MJ, Aisner S, et al. Histopathologic classification of small cell lung cancer changing concepts and terminology. Cancer. 1988;62:973–977.
  • Herbst RS, Heymach JV, Lippman SM. Lung cancer. N Engl J Med. 2008;359:1367–1380. doi:10.1056/NEJMra0802714
  • Aupérin A, Arriagada R, Pignon JP, et al. Prophylactic cranial irradiation for patients with small cell lung cancer in complete remission. N Engl J Med. 1999;341(7):476⁃484. doi:10.1056/NEJM199908123410703
  • Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin. 2011;61:69–90. doi:10.3322/caac.20107
  • Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer. 2010;127:2893–2917. doi:10.1002/ijc.25516
  • Govindan R, Page N, Morgensztern D, et al. Changing epidemiology of small-cell lung cancer in the United States over the last 30 years: analysis of the surveillance, epidemiologic, and end results database. Clin Oncol. 2006;24:4539–4544. doi:10.1200/JCO.2005.04.4859
  • Amini A, Byers LA, Welsh JW, Komaki RU. Progress in the management of limited-stage small cell lung cancer. Cancer. 2014;120:790–798. doi:10.1002/cncr.28505
  • Meert AP, Paesmans M, Berghmans T, et al. Prophylactic cranial irradiation in small cell lung cancer: a systematic review of the literature with meta-analysis. BMC Cancer. 2001;1:5. doi:10.1186/1471-2407-1-5
  • Yin X, Yan D, Qiu M, Huang L, Yan SX. Prophylactic cranial irradiation in small cell lung cancer: a systematic review and meta-analysis. BMC Cancer. 2019;19:95. doi:10.1186/s12885-018-5251-3
  • Gong L, Wang QI, Zhao L, Yuan ZY, Li RJ, Wang P. Factors affecting the risk of brain metastasis in small cell lung cancer with surgery: is prophylactic cranial irradiation necessary for stage I-III disease? Int J Radiat Oncol Biol Phys. 2013;85:196–200. doi:10.1016/j.ijrobp.2012.03.038
  • Tsuchiya R, Suzuki K, Ichinose Y, et al. Phase II trial of postoperative adjuvant cisplatin and etoposide in patients with completely resected stage I-IIIa small cell lung cancer: the Japan Clinical Oncology Lung Cancer Study Group Trial (JCOG9101). J Thorac Cardiovasc Surg. 2005;129:977–983. doi:10.1016/j.jtcvs.2004.05.030
  • Nakamura H, Kato Y, Kato H. Outcome of surgery for small cell lung cancer – response to induction chemotherapy predicts survival. Thorac Cardiovasc Surg. 2004;52:206–210. doi:10.1055/s-2004-821075
  • Ogawa S, Horio Y, Yatabe Y, et al. Patterns of recurrence and outcome in patients with surgically resected small cell lung cancer. Int J Clin Oncol. 2012;17:218–224. doi:10.1007/s10147-011-0277-4
  • Zhu H, Bi Y, Han A, et al. Risk factors for brain metastases in completely resected small cell lung cancer: a retrospective study to identify patients most likely to benefit from prophylactic cranial irradiation. Radiat Oncol. 2014;9:216. doi:10.1186/1748-717X-9-216
  • Meng-yuan C, Xiao H, Yong B, et al. Comparison of long term results between matched chemoradiotherapy and surgery for limited stage small cell lung cancer. Cancer Manag Res. 2019;11:9049–9055. doi:10.2147/CMAR.S222882
  • Mirsadraee S, Oswal D, Alizadeh Y, Caulo A, van Beek E Jr. The 7th lung cancer TNM classification and staging system: review of the changes and implications. World J Radiol. 2012;4:128–134. doi:10.4329/wjr.v4.i4.128
  • Farooqi AS, Emma B, Xiong W, James DC, Ritsuko K, Komaki R. Prophylactic cranial irradiation after definitive chemoradiotherapy for limited-stage small cell lung cancer: do all patients benefit? Radiother Oncol. 2017;122(2):307–312. doi:10.1016/j.radonc.2016.11.012
  • Le Pechoux C, Laplanche A, Faivre-Finn C, et al. Clinical neurological outcome and quality of life among patients with limited small-cell cancer treated with two different doses of prophylactic cranial irradiation in the intergroup Phase III trial (PCI99–01, EORTC 22003–08004, RTOG 0212 and IFCT 99–01). Ann Oncol. 2011;22:1154–1163. doi:10.1093/annonc/mdq576
  • Wolfson AH, Bae K, Komaki R, et al. Primary analysis of a phase II randomized trial Radiation Therapy Oncology Group (RTOG) 0212: impact of different total doses and schedules of prophylactic cranial irradiation on chronic neurotoxicity and quality of life for patients with limited-disease small-cell lung cancer. Int J Radiat Oncol Biol Phys. 2011;81:77–84. doi:10.1016/j.ijrobp.2010.05.013
  • Zeng H, Li R, Hu C, et al. Association of twice-daily radiotherapy with subsequent brain metastases in adults with small cell lung cancer. JAMA Netw Open. 2019;2(5):e190103. doi:10.1001/jamanetworkopen.2019.0103